| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780689 | Gynecologic Oncology | 2018 | 6 Pages |
Abstract
The mGPS is an independent predictor of OS in ROC after adjusting for HRQL and clinicopathological factors. Higher mGPS is associated with worse HRQL independent of PS. mGPS is simple, inexpensive and may be suitable for clinical practice, clinical trial patient selection and stratification.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Felicia T. Roncolato, Dominique Berton-Rigaud, Rachel O'Connell, Anne Lanceley, Jalid Sehouli, Luke Buizen, Aikou Okamoto, Eriko Aotani, Domenica Lorusso, Paul Donnellan, Amit Oza, Elisabeth Avall-Lundqvist, Jonathan Berek, Felix Hilpert,